Researchers at University of California San Diego School of Medicine used a mouse model to demonstrate a process in which neurons switch expression of neurotransmitters in response to day-length stimuli, triggering related behavioral changes. The findings reveal a promising new target for treating disorders associated with seasonal changes in light exposure.
Seasonal changes in light, namely longer days in summer and shorter in winter—have long been associated with changes in human behaviors, affecting everything from sleep and eating patterns to brain and hormonal activity. More serious consequences can include seasonal affective disorder (SAD), a type of depression related to diminished exposure to natural sunlight, typically occurring during winter months and more often at higher latitudes when daylight hours are shortest.
Bright light therapy has proven an effective remedy for treating SAD and conditions like non-seasonal major depression, postpartum depression and bipolar disorder, but how seasonal changes in day length and light exposure affect and alter the brain at the cellular and circuit levels is poorly understood.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Led by Davide Dulcis, PhD, associate professor in the Department of Psychiatry at UC San Diego School of Medicine and a member of the Center for Circadian Biology at UC San Diego, the study investigated suprachiasmatic nucleus (SCN) neurons. Considered the body’s timekeeper, SCNs regulate most circadian rhythms and operate based on input from specialized photosensitive cells in retina, which communicate changes in light and day length to our body.
Dulcis and colleagues found that, in mice, whose brains function similarly to humans, SCNs coordinated with each other to adapt to different lengths of daylight, changing at cellular and network levels. This coordination involved changing the mix and expression of key neurotransmitters that, in turn, alter brain activity and subsequent daily behaviors.
“The most impressive new finding in this study is that we discovered how to artificially manipulate the activity of specific SCN neurons and successfully induce dopamine expression within the hypothalamic PVN [paraventricular nucleus] network,” said Dulcis. PVN is a region of the brain that plays essential roles in controlling stress, metabolism, growth, reproduction, immune and other autonomic functions. Seasonal changes in light exposure have also been shown to alter the number of neurotransmitter-expressing neurons in the PVN.
“We revealed novel molecular adaptations of the SCN-PVN network in response to day length in adjusting hypothalamic function and daily behavior,” says Alexandra Porcu, PhD, a member of Dulcis’ lab. “The multi-synaptic neurotransmitter switching we showed in this study might provide the anatomical/functional link mediating the seasonal changes in mood and the effects of light therapy.”
The authors believe their findings provide a novel mechanism explaining how the brain adapts to seasonal changes in light exposure. Because the adaptation occurs within neurons exclusively located in the SCN, the latter represents a promising target for new treatments for disorders associated with seasonal changes in light exposure.
The findings were published recently in Science Advances.